XRP ETF Decision Countdown: October 18-25 Timeline as DeepSnitch AI Presale Hits $337K
XRP's moment of truth approaches as SEC faces critical ETF decision window
The Regulatory Countdown Begins
With just days until the October 18-25 ETF decision period, XRP traders are positioning for what could be the biggest regulatory catalyst since the SEC lawsuit. The timing couldn't be more dramatic—just as institutional interest in crypto ETFs reaches fever pitch.
AI Presale Defies Market Skepticism
While regulators drag their feet, DeepSnitch AI's presale proves investors aren't waiting around—racking up $337K in funding despite the regulatory uncertainty. Because nothing says 'trust the process' like betting on unregulated AI projects while waiting for government approval.
The Institutional Dilemma
Wall Street's latest paradox: desperate to offer crypto ETFs while simultaneously warning clients about crypto's risks. The ultimate hedge—collect fees regardless of which way the regulatory winds blow.
Decision day looms. Will XRP finally get its institutional stamp of approval, or join the growing graveyard of 'almost-ETFs'? Either way, somebody's getting rich—probably the lawyers.
Image source: Getty Images.
Earnings and offerings
Analysts expected Tilray to lose money yesterday, but the company reported a small surprise profit of $1.5 million instead. (The number rounded down to just $0.00 per share -- but it was a positive $0.00.)
Anticipating the good news WOULD attract investors, Tilray then turned around and announced, in an SEC filing, that it plans to sell "from time to time" enough shares to raise $51.6 million. At today's share price, that could mean as many as 28.7 million new shares flooding onto the market.
Tilray also noted it may issue up to 3,133 shares "upon exercise of certain outstanding warrants."
Last but not least, Tilray noted that one of its shareholders may want to sell 8.6 million shares of Tilray.
Is Tilray stock a sell?
Let's take those announcements one at a time.
28.7 million shares, added to its 149.3 million shares outstanding, means Tilray may soon dilute existing shareholders by 19%. Adding financial insult to ownership-stake injury, selling so many shares will probably depress Tilray's stock price. So too will the selling shareholder unloading 8.6 million more shares.
Tilray investors are right to be upset. Tilray just turned good news into bad news.
